Registro:

Referencias:

• Fais, F., Ghiotto, F., Hashimoto, S., Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors (1998) J Clin Invest, 102, pp. 1515-1525
• Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G., Stevenson, F.K., Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia (1999) Blood, 94, pp. 1848-1854
• Decker, T., Flohr, T., Trautmann, P., Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia (1995) Blood, 86, pp. 1115-1121
• Dazzi, F., D'Andrea, E., Biasi, G., Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens (1995) Clin Immunol Immunopathol, 75, pp. 26-32
• Ranheim, E.A., Kipps, T.J., Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal (1993) J Exp Med, 177, pp. 925-935
• Van den Hove, L.E., Van Gool, S.W., Vandenberghe, P., CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules (1997) Leukemia, 11, pp. 572-580
• Kato, K., Cantwell, M.J., Sharma, S., Kipps, T.J., Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells (1998) J Clin Invest, 101, pp. 1133-1141
• Wierda, W.G., Cantwell, M.J., Woods, S.J., CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia (2000) Blood, 96, pp. 2917-2924
• Decker, T., Schneller, F., Sparwasser, T., Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells (2000) Blood, 95, pp. 999-1006
• Jahrsdorfer, B., Hartmann, G., Racila, E., CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens (2001) J Leukoc Biol, 69, pp. 81-88
• Decker, T., Scneller, F., Kronschnabl, M., Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotype (2000) Exp Hematol, 28, pp. 558-568
• Krieg, A.M., Yi, A.K., Matson, S., CpG motifs in bacterial DNA trigger direct B-cell activation (1995) Nature, 374, pp. 546-549
• Kadowaki, N., Antonenko, S., Liu, Y.J., Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN (2001) J Immunol, 166, pp. 2291-2295
• Krug, A., Rothenfusser, S., Hornung, V., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells (2001) Eur J Immunol, 31, pp. 2154-2163
• Krug, A., Towarowski, A., Britsch, S., Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12 (2001) Eur J Immunol, 31, pp. 3026-3037
• Hartmann, G., Krieg, A.M., Mechanism and function of a newly identified CpG DNA motif in human primary B cells (2000) J Immunol, 164, pp. 944-953
• Sparwasser, T., Koch, E.S., Vabulas, R.M., Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells (1998) Eur J Immunol, 28, pp. 2045-2054
• Ballas, Z.K., Rasmussen, W.L., Krieg, A.M., Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA (1996) J Immunol, 157, pp. 1840-1845
• Hornung, V., Rothenfusser, S., Britsch, S., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides (2002) J Immunol, 168, pp. 4531-4537
• Lipford, G.B., Bauer, M., Blank, C., CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants (1997) Eur J Immunol, 27, pp. 2340-2344
• Chu, R.S., Targoni, O.S., Krieg, A.M., Lehmann, P.V., Harding, C.V., CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity (1997) J Exp Med, 186, pp. 1623-1631
• Moldoveanu, Z., Love-Homan, L., Huang, W.Q., Krieg, A.M., CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus (1998) Vaccine, 16, pp. 1216-1224
• Davis, H.L., Weeratna, R., Waldschmidt, T.J., CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen (1998) J Immunol, 160, pp. 870-876
• Weeratna, R.D., McCluskie, M.J., Xu, Y., Davis, H.L., CpG DNA induces stronger immune responses with less toxicity than other adjuvants (2000) Vaccine, 18, pp. 1755-1762
• Kline, J.N., Waldschmidt, T.J., Businga, T.R., Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma (1998) J Immunol, 160, pp. 2555-2559
• Magone, M.T., Chan, C.C., Beck, L., Whitcup, S.M., Raz, E., Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis (2000) Eur J Immunol, 30, pp. 1841-1850
• Wooldridge, J.E., Ballas, Z., Krieg, A.M., Weiner, G.J., Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma (1997) Blood, 89, pp. 2994-2998
• Carpentier, A.F., Chen, L., Maltonti, F., Delattre, J.Y., Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastorna in mice (1999) Cancer Res, 59, pp. 5429-5432
• Krieg, A.M., CpG motifs in bacterial DNA and their immune effects (2002) Annu Rev Immunol, 20, pp. 709-760
• Elias, F., Flo, J., Lopez, R.A., Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs (2003) J Immunol, 171, pp. 3697-3704
• Rozman, C., Montserrat, E., Chronic lymphocytic leukemia (1995) N Engl J Med, 333, pp. 1052-1057
• Weisenburger, D.D., Armitage, J.O., Mantle cell lymphomaan entity comes of age (1996) Blood, 87, pp. 4483-4494
• Flo, J., Massouh, E., Age-related changes of naive and memory CD4 rat lymphocyte subsets in mucosal and systemic lymphoid organs (1997) Dev Comp Immunol, 21, pp. 443-453
• Cook, G.P., Tomlinson, I.M., The human immunoglobulin VH repertoire (1995) Immunol Today, 16, pp. 237-242
• Chang, B., Casali, P., The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement (1994) Immunol Today, 15, pp. 367-373
• Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B., Hallek, M., CD40-activated B-Cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generate different types of effector cells (1999) Blood, 93, pp. 1992-2002
• Collins, R.J., Verschuer, L.A., Harmon, B.V., Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukemia cells following their culture in vitro (1989) Br J Haematol, 71, pp. 343-350
• McConkey, D.J., Aguilar-Santelises, M., Hartzell, P., Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells (1991) J Immunol, 146, pp. 1072-1076
• Yi, A.K., Peckham, D.W., Ashman, R.F., Krieg, A.M., CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway (1999) Int Immunol, 11, pp. 2015-2024
• Wang, Z., Karras, J.G., Colarusso, T.P., Foote, L.C., Rothstein, T.L., Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis (1997) Cell Immunol, 180, pp. 162-167

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------